Brillia Health Cough Control

Product NDC: 72123-007
11-digit product format: 721230007
Labeler code: 72123
Product ID: 72123-007_d5e19d12-636d-2149-e053-2995a90a7be6
Type: HUMAN OTC DRUG
Nonproprietary name: Lapine Bradykinin Immune Globulin (12C, 30C, 50C), Lapine Morphine Immune Globulin (12C, 30C, 50C), Lapine Histamine Immune Globulin (12C, 30C, 50C)
Dosage form: TABLET
Route: ORAL
Labeler: Hadaf LLC
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2020-07-31
Marketing end: 0000-00-00
Substance: LAPINE BRADYKININ IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN; LAPINE MORPHINE IMMUNE GLOBULIN
Active strength: 12 [hp_C]/1; [hp_C]/1; [hp_C]/1
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	72123-007		D	Discontinued by firm		2026-10-12
excluded package	package	72123-007	72123-007-01	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 10 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	72123-007-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	72123-007-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	72123-007-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	72123-007-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	72123-007-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
72123-007-01	2022-10-04	C162847	48780-1	d6a99b39-ad59-a426-e053-dadaa90af4c2	72123-007 Cough Control
72123-007-01	2022-01-28	C162847	48780-1	d6a99b39-ad59-a426-e053-dadaa90af4c2	72123-007 Cough Control

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
72123-007-01	72123000701	2 BLISTER PACK in 1 BOX (72123-007-01) > 10 TABLET in 1 BLISTER PACK	2 blister pack	2020-07-31	0000-00-00	No	No	Current